IL-6 antibody shows no COVID-19 benefit

被引：0
|
作者：
Cross, Ryan
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2020年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [21] Is IL-6 a key cytokine target for therapy in COVID-19?
    Simon A. Jones
    Christopher A. Hunter
    Nature Reviews Immunology, 2021, 21 : 337 - 339
  • [22] Is IL-6 a key cytokine target for therapy in COVID-19?
    Jones, Simon A.
    Hunter, Christopher A.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (06) : 337 - 339
  • [23] Lilly antibody shows promise in COVID-19
    Jarvis, Lisa M.
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (35) : 15 - 15
  • [24] Lilly antibody shows promise in COVID-19
    JARVIS, L. I. S. A. M.
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (36) : 15 - 15
  • [25] Investigation of IL-6 serum level in COVID-19 patients with positive COVID-19 IgG/IgM antibody titers to check inflammation and disease progression
    Mollazadeh, Samaneh
    Mahmoudi, Mahmoud
    Mohammadi, Mojgan
    Kheder, Ramiar Kamal
    Mahallati, Hussein Nasiri
    Haghighi, Salime Sarbaz
    Masoumi, Elnaz
    Javanmardi, Zahra
    Esmaeili, Seyed-Alireza
    CYTOKINE, 2024, 177
  • [26] IL-6 blockade for COVID-19: a global scientific call to arms
    Murthy, Srinivas
    Lee, Todd C.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (05): : 438 - 440
  • [27] Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
    Flisiak, Robert
    Jaroszewicz, Jerzy
    Rogalska, Magdalena
    Lapinski, Tadeusz
    Berkan-Kawinska, Aleksandra
    Bolewska, Beata
    Tudrujek-Zdunek, Magdalena
    Kozielewicz, Dorota
    Rorat, Marta
    Leszczynski, Piotr
    Klos, Krzysztof
    Kowalska, Justyna
    Pabjan, Pawel
    Piekarska, Anna
    Mozer-Lisewska, Iwona
    Tomasiewicz, Krzysztof
    Pawlowska, Malgorzata
    Simon, Krzysztof
    Polanska, Joanna
    Zarebska-Michaluk, Dorota
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [28] Clinical significance of IL-6 in severe and critical COVID-19 patients
    Kawamata, Takaya
    Tanino, Yoshinori
    Wang, Xintao
    Nikaido, Takefumi
    Sato, Yuki
    Togawa, Ryuichi
    Watanabe, Natsumi
    Saito, Koshi
    Kazama, Kentaro
    Harigane, Rina
    Yamada, Ryuki
    Tomita, Hikaru
    Rikimaru, Mami
    Morimoto, Julia
    Minemura, Hiroyuki
    Saito, Junpei
    Kanazawa, Kenya
    Shibata, Yoko
    RESPIROLOGY, 2023, 28 : 136 - 136
  • [29] Evolution of IL-6 as possible marker of viral control in Covid-19
    De Diego Ramos, C.
    Lopez, L.
    Torralba, L.
    Lasierra, A.
    Lahoz, R.
    Abadia, C.
    Ruiz De Gopegui, P.
    Cebollada, A.
    Godino, J.
    Jimeno, B.
    Bello, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [30] IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
    Shubham Atal
    Zeenat Fatima
    Pharmaceutical Medicine, 2020, 34 : 223 - 231
12345